1. 213 BRAF mutations are potentially targetable alterations in a wide variety of solid cancers. (September 2015) Authors: Gatalica, Z.; Burnett, K.; Bender, R.; Feldman, R.; Vranic, S.; Reddy, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 215 Using ALK IHC test to identify potential responders to ALK inhibitors outside of NSCLC. (September 2015) Authors: Xiu, J.; Gatalica, Z.; Abbott, B.; Reddy, S.; Vanderwalde, A.; Braiteh, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 254 Multi-platform molecular profiling of 1, 180 patients increases median overall survival and influences treatment decision in 53% of cases. (September 2015) Authors: Spetzler, D.; Xiao, N.; Burnett, K.; Burch, K.; Abbott, B.; Russell, K.; Voss, A.; Gatalica, Z.; Reddy, S.; Leonard, R.; Khayat, D.; Marshall, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2771 BRCA1 and BRCA2 mutations in 1691 epithelial ovarian tumors identify subgroups with distinct molecular characteristics. (September 2015) Authors: Herzog, T.; Xiu, J.; Bender, R.; Gatalica, Z.; Reddy, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S554 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗